Solomon VR

References (6)

Title : Innovative Approaches to Alzheimer's Treatment: Utilizing Tacrine Hybrids to Inhibit Amyloid Beta Aggregation as a Strategic Focus - Prabakaran_2026_Mini.Rev.Med.Chem__
Author(s) : Prabakaran A , Sivaperuman A , Natarajan R , Nagarajan NC , Solomon VR
Ref : Mini Rev Med Chem , : , 2026
Abstract :
PubMedSearch : Prabakaran_2026_Mini.Rev.Med.Chem__
PubMedID: 41510718

Title : Innovative Approaches to Alzheimer's Treatment: Utilizing Tacrine Hybrids to Inhibit Amyloid Beta Aggregation as a Strategic Focus - Prabakaran_2026_Mini.Rev.Med.Chem__
Author(s) : Prabakaran A , Sivaperuman A , Natarajan R , Nagarajan NC , Solomon VR
Ref : Mini Rev Med Chem , : , 2026
Abstract :
PubMedSearch : Prabakaran_2026_Mini.Rev.Med.Chem__
PubMedID: 41510718

Title : Innovative Approaches to Alzheimer's Treatment: Utilizing Tacrine Hybrids to Inhibit Amyloid Beta Aggregation as a Strategic Focus - Prabakaran_2026_Mini.Rev.Med.Chem__
Author(s) : Prabakaran A , Sivaperuman A , Natarajan R , Nagarajan NC , Solomon VR
Ref : Mini Rev Med Chem , : , 2026
Abstract :
PubMedSearch : Prabakaran_2026_Mini.Rev.Med.Chem__
PubMedID: 41510718

Title : Unveiling the mTOR pathway modulation by SGLT2 inhibitors: a novel approach to Alzheimer's disease in type 2 diabetes - Ramakrishan_2025_Metab.Brain.Dis_40_132
Author(s) : Ramakrishan P , Rajangam J , Mahinoor SS , Bisht S , Mekala S , Upadhyay DK , Solomon VR , Sabarees G , Pelluri R
Ref : Metabolic Brain Disease , 40 :132 , 2025
Abstract :
PubMedSearch : Ramakrishan_2025_Metab.Brain.Dis_40_132
PubMedID: 40009301

Title : Unveiling the mTOR pathway modulation by SGLT2 inhibitors: a novel approach to Alzheimer's disease in type 2 diabetes - Ramakrishan_2025_Metab.Brain.Dis_40_132
Author(s) : Ramakrishan P , Rajangam J , Mahinoor SS , Bisht S , Mekala S , Upadhyay DK , Solomon VR , Sabarees G , Pelluri R
Ref : Metabolic Brain Disease , 40 :132 , 2025
Abstract :
PubMedSearch : Ramakrishan_2025_Metab.Brain.Dis_40_132
PubMedID: 40009301

Title : Unveiling the mTOR pathway modulation by SGLT2 inhibitors: a novel approach to Alzheimer's disease in type 2 diabetes - Ramakrishan_2025_Metab.Brain.Dis_40_132
Author(s) : Ramakrishan P , Rajangam J , Mahinoor SS , Bisht S , Mekala S , Upadhyay DK , Solomon VR , Sabarees G , Pelluri R
Ref : Metabolic Brain Disease , 40 :132 , 2025
Abstract :
PubMedSearch : Ramakrishan_2025_Metab.Brain.Dis_40_132
PubMedID: 40009301